Press Release

MANCHESTER, N.H., Sept. 30, 2024 /PRNewswire/ -- BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic partnership with...

Utilizing Owkin’s expansive data network and cutting-edge AI, this solution optimizes pre-screening for gBRCA mutations in breast cancer directly from digitized H&E pathology slides The solution aims to improve gBRCA...

Proscia: Life sciences organizations can rapidly build AI algorithms to discover biomarkers, optimize clinical trials, and advance companion diagnostics—powered by the first digital pathology platform to seamlessly integrate foundation...

Mindpeak: Funding strengthens the product development roadmap for AI-powered histopathological assessments, supporting clinical labs and biopharma companies worldwide. HAMBURG, Germany--(BUSINESS WIRE)--Mindpeak, the leader in AI-powered...

Ibex Survey discovers that more than 50% of Americans have received incorrect medical test results for themselves or a loved one; 60% would trust AI supporting diagnoses  BOSTON, Sept. 25, 2024 — Ibex Medical Analytics (Ibex), the...

Gestalt and DataPath: The companies are focused on making an impact on healthcare accessibility SPOKANE, Wash., Sept. 16, 2024 /PRNewswire/ -- Gestalt, a leader in AI-driven digital pathology solutions, is excited to announce its...